A Randomized Phase II Study of Adebrelimab in Combination with Chemotherapy with or Without Bevacizumab Neoadjuvant Therapy for Resectable Non-Squamous Non-Small Cell Lung Cancer
Latest Information Update: 21 Jan 2025
Price :
$35 *
At a glance
- Drugs Adebrelimab (Primary) ; Bevacizumab (Primary) ; Carboplatin; Cisplatin; Docetaxel; Nedaplatin; Paclitaxel; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Jan 2025 New trial record